Statistical considerations when using a composite endpoint for comparing treatment groups

DOI10.1002/SIM.5547MaRDI QIDQ94829WikidataFDO

Authors Guadalupe Gómez Melis, Stephen W. Lagakos

Publication date 1 August 2012

Published in Statistics in Medicine (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1002/SIM.5547

Cited in

(1)

• CompAREdesign

This page was built for publication: Statistical considerations when using a composite endpoint for comparing treatment groups

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q94829)